Private company
Atlas Venture Fund XI, L.P.
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
Atlas Venture Fund XI, L.P. sits at the top of its group. 8 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- Atlas Venture Fund XI, L.P. DE
- Akero Therapeutics, Inc. Stake · San Francisco, California, United States
- Day One Biopharmaceuticals, Inc. Stake · Brisbane, California
- Dyne Therapeutics, Inc. Stake · Waltham, Massachusetts
- Korro Bio, Inc. Stake · Cambridge, Massachusetts
- Sionna Therapeutics, Inc. Stake · Waltham, Massachusetts
- Third Harmonic Bio, Inc. Stake · San Francisco, California
- Xilio Therapeutics, Inc. Stake · Waltham, Massachusetts
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (7 companies). Each entity in the chart links to its source.
Stakes it holds
Atlas Venture Fund XI, L.P. has told the SEC it owns more than 5% of 7 companies, latest first (Schedules 13D and 13G).
- Dyne Therapeutics, Inc.SCHEDULE 13G/A Feb 11, 2022 to Aug 13, 20262
- Korro Bio, Inc.SCHEDULE 13D/A Nov 13, 2023 to Aug 4, 20263
- Day One Biopharmaceuticals, Inc.SCHEDULE 13G/A Feb 11, 2022 to May 14, 20264
- Sionna Therapeutics, Inc.SCHEDULE 13D/A Feb 18, 2025 to Oct 20, 20255
- Xilio Therapeutics, Inc.SC 13G/A Nov 5, 2021 to Nov 14, 20246
- Third Harmonic Bio, Inc.SC 13D/A Sep 29, 2022 to Nov 5, 20247
- Akero Therapeutics, Inc.SC 13G/A Feb 11, 2022 to Feb 14, 20238
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8